Between Two Worlds: Doing Business as a Cell and Gene Academic
December 30, 2022
The pharmaceutical industry depends on academia, but that relationship – and its points of interchange – could be improved
6 min read
2022
Know Your Vectors: a 101 on Lentiviral Therapies
December 28, 2022
Everything you ever wanted to know (but were too afraid to ask) about in vivo and ex vivo lentiviral vector therapies
5 min read
Advanced – But Not Advanced Enough
December 27, 2022
Great successes are being seen in gene therapy, but there are still gaps in our scientific knowledge – and our manufacturing prowess
12 min read
Take Another Look
December 23, 2022
Genentech goes beyond pharmaceutical manufacturing in its work with members of the SMA community, who want to draw gazes with their involvement in the world of fashion. Michael Dunn explains.
4 min read
The Cords that Bind
December 22, 2022
A quick guide to a cell therapy starting material that demands a little more attention: cord blood
4 min read
Cell and Gene EuroZingers
December 21, 2022
More than a few pearls of wisdom were dropped just outside Hyde Park, and we were there to pick up some of the best
7 min read
#MemeTeam
December 20, 2022
Rounding up responses to an FDA tweet promoting COVID-19 bivalent vaccine boosters
4 min read
Final Call for Voting in the Company of the Year Awards
December 19, 2022
Voting will close on December 21
1 min read
A Day in Egg City: Seven Things I Learned on a Visit to Britain’s Largest Flu Vaccine Factory
December 16, 2022
From hemispheric analysis to hatchery logistics, there’s a lot more to vaccine production than you might suspect
8 min read
Cancer Clinical Trials: The Where’s Waldo? Puzzle No One Wants
December 15, 2022
Massive Bio co-founders Selin Kurnaz and Arturo Loaiza-Bonilla discuss the difficulty in finding candidates for oncology clinical trials
7 min read
